| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC COM | 4,780,188 | 386,526,000 | 79.39% | ||
| 2 | IMMUNE DESIGN CORP COM | 1,983,858 | 40,967,000 | 8.41% | ||
| 3 | Agile Therapeutics, Inc. | 4,668,663 | 40,104,000 | 8.24% | ||
| 4 | ANTHERA PHARMACEUTICALS I | 1,900,000 | 16,378,000 | 3.36% | ||
| 5 | Zosano Pharma Corp | 229,759 | 1,666,000 | 0.34% | ||
| 6 | MAST THERAPEUTICS | 2,551,851 | 1,250,000 | 0.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-032441, filed 2015.08.17).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
